Drug Profile
DSP 1200
Alternative Names: DSP-1200Latest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator Sumitomo Dainippon Pharma
- Developer Sumitomo Pharma
- Class Antidepressants
- Mechanism of Action Alpha 2a adrenergic receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Depressive disorders